Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% sinc ...

Ascendis, Bayer, Boehringer Ingelheim, Jazz Pharmaceuticals, Novo Nordisk, Sanofi, and Teva to keynote sharing innovations to drive better patient outcomes BARCELONA, Spain, May 21, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from Ascendis Pharma A/S, Bayer, Boehringer Ingelheim, Jazz Pharmaceuticals, Novo Nordisk, Sanofi, and Teva will be keynote speakers at Veeva R&D and Quality Summit, Europe, June 4-5 in Madrid, Spain. Life sciences professionals across the industry will ...

Veeva Systems (VEEV) recently announced the availability of Vault Basics, a new offering that includes technology, training, and support designed for biotechs. Vault Basics enables rapidly expanding businesses to employ market-leading Veeva Vault applications, without any upfront or maintenance costs. Applications developed on industry best practices can be swiftly adopted by biotechs, providing a basis for scaling and growth management. Vault Basics is live at 10 biotechs to promote speed, compliance, and ...

Delivers industry-leading Vault applications in a turnkey solution with no implementation costs for simple adoption PLEASANTON, Calif., May 16, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of Veeva Vault Basics, a new offering that includes technology, training, and support designed for biotechs. Vault Basics equips fast-growing companies to deploy industry-leading Veeva Vault applications with zero implementation and maintenance costs. Biotechs can quickly adopt applicat ...

Veeva Systems Inc. (VEEV) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid fourth-quarter fiscal 2024 performance and strategic deals, is expected to contribute further. Stiff competition and data security threats persist. Over the past six months, this current Zacks Rank #2 (Buy) stock has gained 28.6% compared with 12.6% growth of the industry and a 16.6% rise of the S&P 500 Composite. The renowned provider of cloud-based software app ...

Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $6.14 per share and revenue of $2.73 billion, indicating changes of +26.86% and +15.61%, respectively, compared to the previous year. Investors should also note any recent changes to analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. Th ...

Veeva Systems (VEEV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this provider of cloud-based software services for the life sciences industry have returned -5.2%, compared to the Zacks S&P 500 composite's -0.2% change. During this period, the Zacks Internet - Software industry, which Veeva falls in, has lost 6.8%. The key question now is: What could ...

Veeva Systems (VEEV) ended the recent trading session at $203.14, demonstrating a -0.15% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.03%. Elsewhere, the Dow saw an upswing of 0.46%, while the tech-heavy Nasdaq appreciated by 1.19%.The the stock of provider of cloud-based software services for the life sciences industry has fallen by 5.25% in the past month, lagging the Computer and Technology sector's loss of 0.68% and the S&P 500's loss of ...

In the latest market close, Veeva Systems (VEEV) reached $201.58, with a +0.33% movement compared to the previous day. This move outpaced the S&P 500's daily gain of 0.32%. At the same time, the Dow added 0.38%, and the tech-heavy Nasdaq gained 0.35%.Heading into today, shares of the provider of cloud-based software services for the life sciences industry had lost 13.29% over the past month, lagging the Computer and Technology sector's loss of 1.9% and the S&P 500's loss of 2% in that time.Investors will be ...

Veeva Systems (VEEV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this provider of cloud-based software services for the life sciences industry have returned -14.1% over the past month versus the Zacks S&P 500 composite's -3.2% change. The Zacks Internet - Software industry, to which Veeva belongs, has lost 9.4% over this period. Now the key question is: Where could the st ...